USA Financial Formulas’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466 Hold
1
﹤0.01% 388
2026
Q1
$378 Hold
1
﹤0.01% 416
2025
Q4
$428 Buy
+1
New +$435 ﹤0.01% 402
2019
Q1
Sell
-1,902
Closed -$608K 157
2018
Q4
$608K Buy
1,902
+1,024
+117% +$309K 0.15% 105
2018
Q3
$283K Buy
+878
New +$280K 0.07% 221
2017
Q3
Sell
-1,427
Closed -$292K 261
2017
Q2
$292K Buy
+1,427
New +$284K 0.07% 214
2017
Q1
Sell
-7,240
Closed -$1.16M 253
2016
Q4
$1.16M Sell
7,240
-631
-8% -$92.7K 0.29% 74
2016
Q3
$1.11M Sell
7,871
-5,035
-39% -$701K 0.28% 79
2016
Q2
$1.76M Buy
+12,906
New +$1.71M 0.48% 63

Other funds holding CHE

USA Financial Formulas's CHE Position: Q2 2026 in Review

USA Financial Formulas held its Chemed (CHE) position steady in Q2 2026 at 1 share worth $466. The position accounts for ﹤0.01% of the portfolio, ranked #388.

USA Financial Formulas first reported a position in CHE in Q2 2016 and has held it in 9 quarters since. The position peaked at $1.76M in Q2 2016. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • USA Financial Formulas held 1 share of Chemed worth $466 as of Q2 2026.
  • USA Financial Formulas left its Chemed share count unchanged in Q2 2026.
  • Chemed made up ﹤0.01% of USA Financial Formulas's portfolio in Q2 2026, its #388 holding.
  • USA Financial Formulas first reported a position in Chemed in Q2 2016 and has held it in 9 quarters since.
  • USA Financial Formulas's Chemed position peaked at $1.76M in Q2 2016.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.